Contraindicated during pregnancy
Do not use this medicine during pregnancy.
Leaflet TARKA 180mg / 2mg prolonged-release tablets
- Product code:
- W62349001
- Quantity:
- 28
- Indicated for:
- hypertension
- Route of administration:
- oral
- Substance:
- verapamil + trandolapril (calcium channel blocker + ACE inhibitor)
- ATC
- C09BB10 — Cardiovascular system | Ace inhibitors, combinations | Ace inhibitors and calcium channel blockers
Precautions:
Avoid grapefruit
Avoid grapefruit and grapefruit juice.
Hypotension / fall risk
May lower blood pressure and increase the risk of falls.
Major drug interactions
This medicine may have important interactions with other medicines.
Requires periodic laboratory tests
Periodic laboratory tests may be required during treatment.
Electrolyte disturbances
This medicine may change blood electrolyte levels.
The combination of verapamil and trandolapril is used for the treatment of hypertension and cardiovascular diseases, particularly in patients who require both a calcium channel blocker and an angiotensin-converting enzyme (ACE) inhibitor. Verapamil is a calcium channel blocker that relaxes blood vessels and reduces heart rate, improving blood flow and lowering blood pressure. Trandolapril is an ACE inhibitor that reduces the production of angiotensin II, a hormone that causes blood vessel constriction.
This combination is administered orally, usually once daily, and the dosage is adjusted based on the patient's response and blood pressure levels. It is important for patients to adhere to the treatment and regularly monitor their blood pressure.
Common side effects include dizziness, headaches, nausea, and fatigue. In rare cases, severe adverse reactions such as severe hypotension, hyperkalemia, or allergic reactions may occur.
The combination of verapamil and trandolapril provides an effective option for managing hypertension and cardiovascular diseases, helping to reduce the risk of complications such as myocardial infarction or stroke.
This combination is administered orally, usually once daily, and the dosage is adjusted based on the patient's response and blood pressure levels. It is important for patients to adhere to the treatment and regularly monitor their blood pressure.
Common side effects include dizziness, headaches, nausea, and fatigue. In rare cases, severe adverse reactions such as severe hypotension, hyperkalemia, or allergic reactions may occur.
The combination of verapamil and trandolapril provides an effective option for managing hypertension and cardiovascular diseases, helping to reduce the risk of complications such as myocardial infarction or stroke.
General data about TARKA 180mg / 2mg
- Substance:
- verapamil + trandolapril
- Date of latest medicines list:
- 01-06-2026
- Product code:
- W62349001
- Concentration:
- 180mg / 2mg
- Pharmaceutical form:
- prolonged-release tablets
- Quantity:
- 28
- Product type:
- Original
- Price:
- 56.57 RON
- Prescription status:
- P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.
Pharmaceutical forms available for verapamil + trandolapril
Concentrations available for verapamil + trandolapril
- 180mg+2mg
- 180mg/2mg
- 240mg/2mg
- 240mg/4mg
Compensation lists for TARKA 180mg / 2mg Mylan
B - Sublist B with 50% discount from the reference price
- Price
- 56.57 RON
- Copayment
- 28.28 RON
- Patient
- 28.29 RON